Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Steven Hager"'
Autor:
Elizabeth Evans, Nagashree Seetharamu, Crystal Mallow, Maurice Zauderer, Barbara Burtness, Marya Chaney, Alexander Spira, Conor Steuer, Tarek Mekhail, J Thaddeus Beck, Douglas Adkins, Terrence Fisher, Amber Foster, John Leonard, Nabil F Saba, Megan Baumgart, Steven Hager, Christopher Chay
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b0d9d82d46d944f0bc9f5f99a3a31fd0
Autor:
Alessandra Fabi, Steven Hager, Laura Lourdes, Rebecca Pedersini, Paola Malaguti, Elizabeth M. Gavioli, Renuka Wakade, Pier Adelchi Ruffini, Francesco Sergio, Manuela Leone, Flavio Mantelli, Marcello Allegretti, Anne Blaes
Publikováno v:
Cancer Research. 83:OT1-16
Introduction: Cancer-related fatigue (CRF) is a common symptom in patients with metastatic breast cancer (MBC), who receive taxane-based chemotherapy, and is associated with poor outcomes. Current guidelines recommend regular screening for fatigue fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac25e12ee04f434a014eae3bae5214c
https://doi.org/10.1158/1538-7445.sabcs22-ot1-16-01
https://doi.org/10.1158/1538-7445.sabcs22-ot1-16-01
Publikováno v:
Anticancer Research. 42:441-447
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8da0838bed46a221a366ee0ddbf4d784
https://doi.org/10.21873/anticanres.15502
https://doi.org/10.21873/anticanres.15502
Autor:
null Aaron Almeida, null David Chau, null Thomas Coolidge, null Hani El‐Sabbahy, null Steven Hager, null Kevin Jose, null Masa Nakamura, null Alexei Voloshin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::232a474a99a39413fed4eff7d51f44da
https://doi.org/10.1002/btpr.3227/v2/response1
https://doi.org/10.1002/btpr.3227/v2/response1
Autor:
Alexei M. Voloshin, David Chau, Thomas Coolidge, Hani El-Sabbahy, Kevin Jose, Steven Hager, Aaron Almeida, Masa Nakamura
Publikováno v:
Biotechnology progress. 38(2)
Recent advancements in cell culture engineering have allowed drug manufacturers to achieve higher productivity by driving higher product titers through cell line engineering and high cell densities. However, these advancements have shifted the burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf66cc820ae0a68d4ace3d67ef518d5
https://pubmed.ncbi.nlm.nih.gov/34854259
https://pubmed.ncbi.nlm.nih.gov/34854259
Autor:
Terrence L. Fisher, Elizabeth E. Evans, Crystal Mallow, Amber Foster, Megan Boise, Ernest Smith, John E. Leonard, Marya F. Chaney, J. Thaddeus Beck, Steven Hager, Nabil F. Saba, Conor Steuer, Douglas Adkins, Barbara Burtness, Maurice Zauderer
Publikováno v:
Cancer Research. 82:CT111-CT111
Purpose: Immunosuppressive myeloid cells in the tumor microenvironment (TME) limit the efficacy of immune checkpoint inhibitors (ICIs) in head and neck squamous cell carcinoma (HNSCC). Preclinical and clinical studies demonstrated that antibody block
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5604310f91e237445e21069f031e5cf
https://doi.org/10.1158/1538-7445.am2022-ct111
https://doi.org/10.1158/1538-7445.am2022-ct111
Publikováno v:
Journal of Cancer Therapy. :254-269
In most cases, cancer develops as a result of non-inheritable somatic mutations (epimutations), acquired by the individual adult cell, during the evolution of the cell, and propagated into an expanding clone of progeny of the cells by natural selecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1abc7a99e502aa6ce559483c7634c50
https://doi.org/10.4236/jct.2016.74027
https://doi.org/10.4236/jct.2016.74027
Autor:
Tatjana Kolevska, Normand Blais, J. von Pawel, Mark U. Rarick, S. Gadgeel, Alberto Chiappori, David R. Spigel, Joan H. Schiller, Martin Reck, Steven Hager, Bart Burington, Lowell L. Hart, Ekaterina Bassett
Publikováno v:
Annals of Oncology. 26:354-362
Imetelstat, a novel telomerase inhibitor, failed to improve significantly median PFS and OS as maintenance therapy (±bevacizumab) in advanced NSCLC. Telomere length (TL) biomarker results were consistent with the hypothesis that telomerase inhibitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a76622af4d486d892be15b322f2a1979
https://doi.org/10.1093/annonc/mdu550
https://doi.org/10.1093/annonc/mdu550
Publikováno v:
Journal of Cancer Therapy. :1013-1019
This article discusses the role of epithelial mesenchymal transition (EMT) and addresses the scientific merits on epigenetic regulation of EMT. The importance of EMT as a prognostic biomarker is explored and the rationale on application of multitarge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cdc8a11c92d122be44e38d922ef657b
https://doi.org/10.4236/jct.2015.611110
https://doi.org/10.4236/jct.2015.611110
Autor:
William Lyons, Marshall Flam, Steven Hager, Jonathan B. Blitzer, Robert A. Nagourney, Barbara L. Sommers, Steven S. Evans, John S. Link
Publikováno v:
Clinical Breast Cancer. 8:432-435
Purpose The combination of cisplatin plus gemcitabine is active in metastatic breast cancer. Carboplatin plus gemcitabine, widely used in ovarian and non–small-cell lung cancers, has also been used in breast cancer. This trial examined the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a32b78710d065f1e1ca553d1121097
https://doi.org/10.3816/cbc.2008.n.052
https://doi.org/10.3816/cbc.2008.n.052